StockNews.com started coverage on shares of Insulet (NASDAQ:PODD – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the medical instruments supplier’s stock. PODD has been the topic of several other reports. JPMorgan Chase & Co. cut their price objective on shares of Insulet from $365.00 to $325.00 […]